Concordia International Corp. (TSE:CXR – Get Free Report) (NASDAQ:CXRX) shares traded down 1.5% during trading on Tuesday . The stock traded as low as C$25.01 and last traded at C$25.04. 73,541 shares were traded during mid-day trading, an increase of 1,714% from the average session volume of 4,054 shares. The stock had previously closed at C$25.43.
Concordia International Stock Performance
The company has a debt-to-equity ratio of 457.02, a current ratio of 2.10 and a quick ratio of 1.66. The business’s 50 day simple moving average is C$25.04. The firm has a market cap of C$1.22 billion and a PE ratio of 0.07.
Concordia International Company Profile
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Further Reading
- Five stocks we like better than Concordia International
- How to Invest in Blue Chip Stocks
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How to Calculate Inflation Rate
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- What to Know About Investing in Penny Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.
